Flow cytometry:AUL: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
| Line 27: | Line 27: | ||
*[[Blastic plasma dendritic cell neoplasm]] | *[[Blastic plasma dendritic cell neoplasm]] | ||
*[[Plasma cell leukaemia]] | *[[Plasma cell leukaemia]] | ||
|colspan="2" style = "font-size:90%; color:black; background:#ddeee1" |'''Requirement 3''' | |||
|- | |- | ||
|colspan="2" style = "font-size:90%; color:black;"|Consider whether the case may be better described as Acute Leukaemia of Ambiguous Lineage - not otherwise specified (ALAL-NOS) - see guidance | |colspan="2" style = "font-size:90%; color:black;"|Consider whether the case may be better described as Acute Leukaemia of Ambiguous Lineage - not otherwise specified (ALAL-NOS) - see guidance | ||
Revision as of 14:58, 22 December 2023
.
| What features must be met to diagnose acute undifferentiated leukaemia | |||
|---|---|---|---|
| Requirement 1 | |||
| No lineage can be assigned by lineage-defining markers of myeloid, B-lymphoid or T-lymphoid lineage
Review Criteria: | |||
| Requirement 2 | |||
| Ensure that other conditions that may resemble undifferentiated acute leukaemia are excluded: particularly consider whether marker patterns suggest any of the following: | Requirement 3 | ||
| Consider whether the case may be better described as Acute Leukaemia of Ambiguous Lineage - not otherwise specified (ALAL-NOS) - see guidance |